Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 9:31 PM View:  | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 18-Nov-24 | Sale | 7,246 | $10.78 | $78,111.90 | (6%) 117.13K to 109.89K | |
| 20-Nov-24 9:30 PM View: | Sarchi Christopher Chief Commercial Officer | Replimune Group, Inc. (REPL) | 18-Nov-24 | Sale | 5,207 | $10.78 | $56,131.50 | (6%) 92.25K to 87.05K | |
| 30-Aug-24 8:00 PM View: | Astley-Sparke Philip Executive Chairman Director | Replimune Group, Inc. (REPL) | 30-Aug-24 | Gift | 50,000 | -- | -- | (3%) 1.49M to 1.44M | |
| 10-Jun-24 8:30 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 07-Jun-24 | Sale (Planned) | 15,881 | $7.50 | $119,108.00 | (12%) 133.01K to 117.13K | |
| 20-May-24 8:00 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 6,367 | $6.47 | $41,194.50 | (5%) 139.38K to 133.01K | |
| 20-May-24 8:05 PM View: | Love Colin Chief Operating Officer | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 17,615 | $6.47 | $113,969.00 | (2%) 794.96K to 777.35K | |
| 20-May-24 8:01 PM View: | Patel Sushil Chief Executive Officer Director | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 20,194 | $6.47 | $130,655.00 | (9%) 232.21K to 212.01K | |
| 20-May-24 8:06 PM View: | Schwendenman Andrew Chief Accounting Officer | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 2,298 | $6.47 | $14,868.10 | (6%) 40.54K to 38.24K | |
| 20-May-24 8:06 PM View: | Sarchi Christopher Chief Commercial Officer | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 2,218 | $6.47 | $14,350.50 | (2%) 94.47K to 92.25K | |
| 20-May-24 8:02 PM View: | Coffin Robert Director | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 11,464 | $6.47 | $74,172.10 | (< 1%) 1.83M to 1.82M | |
| 20-May-24 8:04 PM View: | Astley-Sparke Philip Executive Chairman Director | Replimune Group, Inc. (REPL) | 16-May-24 | Sale | 37,928 | $6.47 | $245,394.00 | (2%) 1.53M to 1.49M | |
| 03-Apr-24 8:00 PM View: | Schwendenman Andrew Chief Accounting Officer | Replimune Group, Inc. (REPL) | 01-Apr-24 | Grant | 17,775 | -- | -- | 78% 22.76K to 40.54K | |
| 03-Apr-24 8:02 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 01-Apr-24 | Grant | 26,665 | -- | -- | 24% 112.71K to 139.38K | |
| 03-Apr-24 8:01 PM View: | Hill Emily Luisa Chief Financial Officer | Replimune Group, Inc. (REPL) | 01-Apr-24 | Grant | 26,665 | -- | -- | 32% 83.33K to 110.0K | |
| 03-Apr-24 8:01 PM View: | Sarchi Christopher Chief Commercial Officer | Replimune Group, Inc. (REPL) | 01-Apr-24 | Grant | 22,225 | -- | -- | 31% 72.25K to 94.47K | |
| 03-Apr-24 8:03 PM View: | Patel Sushil Chief Executive Officer Director | Replimune Group, Inc. (REPL) | 01-Apr-24 | Grant | 83,335 | -- | -- | 56% 148.87K to 232.21K | |
| 17-Nov-23 8:00 PM View: | Sarchi Christopher Chief Commercial Officer | Replimune Group, Inc. (REPL) | 16-Nov-23 | Sale | 5,255 | $10.92 | $57,384.60 | (7%) 77.5K to 72.25K | |
| 17-Nov-23 8:01 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 16-Nov-23 | Sale | 7,313 | $10.92 | $79,858.00 | (6%) 120.03K to 112.71K | |
| 20-Sep-23 8:04 PM View: | Hill Emily Luisa Chief Financial Officer | Replimune Group, Inc. (REPL) | 18-Sep-23 | Grant | 83,330 | -- | -- | 100% 0 to 83.33K | |
| 13-Sep-23 9:02 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 12-Sep-23 | Option Exercise | 300 | $3.30 | $990.00 | < 1% 263.44K to 263.74K | |
| 13-Sep-23 9:02 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 12-Sep-23 | Planned Option Sale | 300 | $20.00 | $6,000.00 | (< 1%) 263.74K to 263.44K | |
| 13-Sep-23 9:02 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 11-Sep-23 | Planned Option Sale | 5,358 | $20.01 | $107,214.00 | (2%) 268.79K to 263.44K | |
| 13-Sep-23 9:02 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 11-Sep-23 | Option Exercise | 5,358 | $3.30 | $17,681.40 | 2% 263.44K to 268.79K | |
| 24-Aug-23 8:30 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 22-Aug-23 | Option Exercise | 18,600 | $6.58 | $122,380.00 | 7% 263.44K to 282.04K | |
| 24-Aug-23 8:30 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 22-Aug-23 | Planned Option Sale | 18,600 | $20.01 | $372,186.00 | (7%) 282.04K to 263.44K | |
| 15-Aug-23 8:30 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 11-Aug-23 | Option Exercise | 1,400 | $3.30 | $4,620.00 | < 1% 263.44K to 264.84K | |
| 15-Aug-23 8:30 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 11-Aug-23 | Planned Option Sale | 1,400 | $20.00 | $28,000.00 | (< 1%) 264.84K to 263.44K | |
| 11-Jul-23 9:00 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 10-Jul-23 | Planned Option Sale | 20,000 | $21.58 | $431,541.00 | (7%) 283.44K to 263.44K | |
| 11-Jul-23 9:00 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 10-Jul-23 | Option Exercise | 20,000 | $6.35 | $127,000.00 | 8% 263.44K to 283.44K | |
| 15-Jun-23 9:00 PM View: | Patel Sushil Chief Strategy Officer | Replimune Group, Inc. (REPL) | 13-Jun-23 | Market Sale (Planned) | 5,698 | $24.05 | $137,008.00 | (4%) 154.57K to 148.87K | (8%) |
| 15-Jun-23 9:01 PM View: | Lewis Tanya Chief Dev. Op. Officer | Replimune Group, Inc. (REPL) | 13-Jun-23 | Market Sale (Planned) | 12,860 | $24.06 | $309,395.00 | (9%) 148.15K to 135.29K | (8%) |
| 18-May-23 8:35 PM View: | Coffin Robert President & Chief R&D Officer Director | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 7,861 | $18.05 | $141,891.00 | (< 1%) 1.84M to 1.83M | |
| 18-May-23 8:31 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 771 | $18.05 | $13,916.50 | (< 1%) 120.8K to 120.03K | |
| 18-May-23 8:36 PM View: | Patel Sushil Chief Strategy Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 15,575 | $18.05 | $281,129.00 | (9%) 170.15K to 154.57K | |
| 18-May-23 8:34 PM View: | Lewis Tanya Chief Dev. Op. Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 12,207 | $18.05 | $220,336.00 | (8%) 160.36K to 148.15K | |
| 18-May-23 8:31 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 5,966 | $18.05 | $107,686.00 | (2%) 269.4K to 263.44K | |
| 18-May-23 8:32 PM View: | Franchi Jean M. Chief Financial Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 11,351 | $18.05 | $204,886.00 | (8%) 140.1K to 128.75K | |
| 18-May-23 8:30 PM View: | Astley-Sparke Philip Chief Executive Officer Director | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 17,902 | $18.05 | $323,131.00 | (1%) 1.54M to 1.53M | |
| 18-May-23 8:33 PM View: | Love Colin Chief Operating Officer | Replimune Group, Inc. (REPL) | 16-May-23 | Sale | 10,775 | $18.05 | $194,489.00 | (1%) 805.74K to 794.96K | |
| 04-Apr-23 8:01 PM View: | Patel Sushil Chief Strategy Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 40,000 | -- | -- | 31% 130.15K to 170.15K | |
| 04-Apr-23 8:01 PM View: | Lewis Tanya Chief Dev. Op. Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 40,000 | -- | -- | 33% 120.36K to 160.36K | |
| 04-Apr-23 8:01 PM View: | Franchi Jean M. Chief Financial Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 45,000 | -- | -- | 47% 95.1K to 140.1K | |
| 04-Apr-23 8:00 PM View: | Astley-Sparke Philip Chief Executive Officer Director | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 142,100 | -- | -- | 10% 1.4M to 1.54M | |
| 04-Apr-23 8:01 PM View: | Love Colin Chief Operating Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 40,000 | -- | -- | 5% 765.74K to 805.74K | |
| 04-Apr-23 8:00 PM View: | Coffin Robert President & Chief R&D Officer Director | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 45,000 | -- | -- | 3% 1.8M to 1.84M | |
| 04-Apr-23 8:02 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 50,000 | -- | -- | 71% 70.8K to 120.8K | |
| 04-Apr-23 8:02 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 01-Apr-23 | Grant | 40,000 | -- | -- | 17% 229.4K to 269.4K | |
| 13-Dec-22 8:01 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 09-Dec-22 | Option Exercise | 15,000 | $1.01 | $15,150.00 | 7% 229.4K to 244.4K | |
| 13-Dec-22 8:01 PM View: | Esposito Pamela Chief Business Officer | Replimune Group, Inc. (REPL) | 09-Dec-22 | Planned Option Sale | 15,000 | $25.03 | $375,450.00 | (6%) 244.4K to 229.4K | |
| 05-Dec-22 8:01 PM View: | Xynos Konstantinos Chief Medical Officer | Replimune Group, Inc. (REPL) | 01-Dec-22 | Grant | 17,500 | -- | -- | 33% 53.3K to 70.8K |
